CU Division of
Gastroenterology & Hepatology Ranks Among Top Programs in U.S.
The 2016 U.S. Newsand World Report “Best Hospitals” rankings have shown a remarkable rise
in the rankings for Gastroenterology and GI surgery to 22nd in the
U.S. Notably, the new rankings put
Colorado ahead of traditional powerhouses such as Michigan, Yale, Duke,
Barnes-Jewish/Washington University, Brigham and Women’s Hospital/Harvard, and
University of Chicago. David Schwartz,
MD, the Chair of Medicine says, "The
U.S. News and World Reports rankings are a well-deserved recognition of our
outstanding program in GI and Hepatology that is built on visionary leadership
and a persistent focus on career development."
Dr. Hugo R. Rosen, MD, Waterman Professor of Medicine and Division
Head of GI since 2005, who has recruited over 45 faculty members, stated: “This is
clear validation of the outstanding and dedicated individuals, recognized
internationally for their expertise, who have made this an extraordinary
program. For years, I have known we had
the very best in the multiple and complex areas within GI and liver disease;
these individuals deserve the accolades.
Our objective is to continue to build new programs that translate
cutting-edge research into advances for patient treatments.”
and Liver Immunology Selected by Dean as Critical Area for Transformation
In late January 2016, CU School of Medicine Dean John J. Reilly, Jr., MD, announced five proposals that will receive funding under the School’s Transformational Research Funding awards. Faculty members in the Department of Medicine will participate in all five of these proposals, with a total of 10 DOM faculty members helping to lead projects.
Congratulations Sean Colgan, PhD and Hugo Rosen, MD
Please join me in congratulating Mihir Wagh and Sachin Wani for
being promoted to Associate Professor.
Mihir performed his internship, residency and chief
medical residency at Columbia University-affiliated St. Vincent’s Medical
Center. That was followed by a Fellowship in Gastroenterology and
Hepatology at Brigham and Women’s Hopsital/Harvard Medical School. He
then performed additional training in Advanced Endoscopy and Endoscopic
Ultrasound at University of Chicago and then at Indiana University. We
were lucky to recruit him from University of Florida where he was on faculty.
Sachin performed an advanced therapeutic endoscopy
fellowship at Washington University after completing his GI fellowship at the
University of Kansas. In the past five years, he has
established himself as a international authority in Barrett’s esophagus, and
his outstanding scholarship has been recognized by multiple, highly-competitive
awards including the Clinical Research Award – American College of
Gastroenterology (March 2011) and American Gastroenterology Association (AGA) –
Takeda Research Scholar Award in Gastroesophageal Reflux Disease and Barrett’s
Esophagus (September 2012). He also leads the Esophageal and Gastric
Center of Excellence at UCH.
5280 Top Docs 2012 for Transplant Hepatology
5280 Magazine, in their 2012 Top Docs listing, says "Today progress is happening at an exponential rate. And many of Denver’s physicians—including the Top Docs profiled on the following pages—are at the forefront of new treatments, cutting-edge procedures, and promising research into how we can further heal an ailing heart.”
Congratulations James Burton, MD and Greg T. Everson, MD, FACP!
Sean Colgan, PhD, Director of Mucosal Inflammation Program receives Endowed Chair
With the vision and hard work of community leaders Jim Eichberg and Phil Karsh, as well as support from the CU Department of Medicine, the University of Colorado's Division of Gastroenterology and Hepatology was able to successfully establish the Levine- Kern Endowed Chair, which is currently held by Sean Colgan, PhD, Director of Mucosal Inflammation Program. The Chair is named after long-time gastroenterology clinical leader and School of Medicine Professor, Dr. Joel Levine and the late Dr. Fred Kern, School of Medicine Professor and head of the Gastroenterology Division at the University of Colorado.
Greg T. Everson, MD, FACP has written a new book
Dr. Everson says, “Hedy Weinberg and I wrote five editions of Living with Hepatitis C: A Survivor’s Guide for the purpose of providing patients and caregivers a resource that could serve as an authoritative readily-available resource. I provided the medical information and Hedy provided the patient perspective by interviewing many patients with HCV to provide a personal connection for the reader. In this new book, Curing Hepatitis C: Current and Future Options for Treatment, I have focused on issues and questions related to the current new standard of treatment, Triple Therapy, and the exciting emerging therapies. As treatment continues to improve, eradication of HCV infection will become increasingly common – the new paradigm will be living without, not with, hepatitis C. Perhaps I am overly optimistic, but I believe that it is entirely possible that the emerging treatments will be so potent and effective that nearly every patient with chronic hepatitis C may be cured by future antiviral therapies!”